Jamshed Iqbal

Title: Jamshed Iqbal: Innovator in Medical Chemistry

Introduction

Jamshed Iqbal is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of medical chemistry, particularly through his innovative patent work. His research focuses on the development of compounds that have potential therapeutic applications.

Latest Patents

Jamshed Iqbal holds a patent for "Phosphorylated A2A receptor agonists." This invention describes a phosphorylated A receptor agonist that provides agonist properties on the A receptor after dephosphorylation. The compound includes a ribosyl moiety and a purine moiety, being phosphorylated at the 5'-position of the ribose moiety, excluding adenosine monophosphate (AMP), adenosine diphosphate (ADP), or adenosine triphosphate (ATP). The patent also discusses a medicament containing the compound and its use for various medical indications, such as inflammatory events.

Career Highlights

Throughout his career, Jamshed Iqbal has worked with reputable organizations, including Crozet Medical GmbH and Rheinische Friedrich-Wilhelms-Universität Bonn. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Jamshed Iqbal has collaborated with notable colleagues, including Jurgen Schrader and Christa Muller. These partnerships have enhanced his research and development efforts, leading to innovative solutions in medical chemistry.

Conclusion

Jamshed Iqbal's work exemplifies the impact of innovation in the medical field. His patent on phosphorylated A2A receptor agonists showcases his commitment to advancing therapeutic options for various medical conditions. His contributions continue to influence the landscape of medical research and development.